News

12
Dec

NativeSkin now available for lab delivery on Mondays!

NativeSkin kit now available for lab delivery on Mondays! We have great news! We have been working hard to optimize our technology and processes this year. We are now able to offer a solution to those seeking to work on our NativeSkin kits throughout the work week. If you order NativeSkin kit, we will prepare and ship them in time for you to receive them on Mondays. Our proprietary
Read more
21
Nov

Genoskin, Inc. renforce son équipe dans la région de Boston

Genoskin, Inc. offre un poste de manager de laboratoire et chef de projet basé à Salem dans la région de Boston (MA), sous la forme d’un Volontariat International en Entreprise (VIE). Venez nous rejoindre ! Rémunération : Compensation nette d’environ 36 K EUR / an + compensation frais hébergement Date de début : Dès que possible Contrat : CDD de 2

Read more

26
Sep

Genoskin signs distribution agreement with Japanese distributor

Genoskin signs distribution agreement with Japan's Fujifilm Wako Pure Chemical The Genoskin team is excited to announce that we've signed an agreement with the Japanese Fujifilm Wako Pure Chemical Corporation to distribute Genoskin's ex vivo human skin models to customers in Japan. This agreement will enable Genoskin to respond to the specific needs of exisiting and potential customers in Japan and to increase its
Read more
6
Sep

New study model for injectable anti-psoriasis drugs

New study model for injectable anti-psoriasis drugs A hi-tech psoriasis skin model to study drug efficacy To evaluate the efficacy of injectable anti-psoriasis drugs, the Genoskin team has designed a new test model that combines the InflammaSkin® and HypoSkin® technologies. Below you’ll find a proof-of-concept case study that illustrates the relevance of the new Hypo-InflammaSkin® model during efficacy studies of injectable
Read more
29
Mar

A unique human skin model to study subcutaneous injections

Ex vivo human skin model to predict toxicity and efficacy of subcutaneous drugs HypoSkin®: a unique ex vivo human skin model for subcutaneous injection testing Subcutaneous biologics market is an emerging area expanding at an impressive average growth rate of 7% to reach € 161 billion by 2024. To date, there is a lack of relevant in vitro biological models to
Read more
14
Mar

3D imaging of invisible skin using light-sheet microscopy

3D imaging of cleared ex vivo human skin using light-sheet fluorescence microscopy The study was a collaborative project with Syntivia and The Institute for Advanced Technology in Life Sciences (ITAV). A promising approach for non-invasive imaging of human skin biopsies Human skin is rich in endogenous fluorophores that can be used as a source of optical contrast. However, 3D imaging
Read more